MetaNovas Secures Funding Rounds as Agentic AI Pioneers Skincare Material Exploration

As "AI for Science" gains momentum, molecular research in laboratories is shifting from digitization to intelligentization.
MetaNovas, a tech company at the forefront of commercializing AI-designed new molecular materials, recently announced the successful completion of two funding rounds: Series A+ and Series A++. The round attracted a strong group of investors—Fuhua Capital, Hillhouse Capital, and the Kangaroo Mom Group—all active in the consumer health sector.
Moving Beyond "Generation-Heavy, Implementation-Light": Getting AI Molecules Out of the Lab
For years, AI in molecular research has faced a core challenge: it can generate countless new molecules via algorithms, but efficiently translating them into real-world production remains difficult. MetaNovas' key breakthrough lies in its Agentic AI R&D System:
Full-Chain Integration: Shifting beyond a focus on isolated technical points, it has achieved a critical leap from "AI-designed molecules" to "AI-implemented molecules."
Compliance and Registration: The AI-designed new molecules have successfully completed the full journey from lab research to consumer market application, and have also passed global new material compliance registration.
Capitalizing on the Consumer Health Market: Leading Brands in China and the U.S. Are Already Onboard
Unlike many AI projects still in the theoretical stage, MetaNovas' technology is already deeply embedded in our daily lives.
Implementation Results: Its self-developed new molecules have entered the supply chains of top cosmetics and medical device brands in both China and the United States.
Industrial Empowerment: By leveraging Agentic AI, brand owners can significantly shorten the development cycle for new ingredients and precisely target niche opportunities in the consumer health market.
Investor Confidence: The "Super Agent" Driving New Material Innovation
This funding round will primarily be used to deepen technology R&D and expand its industrial footprint. As Shanghai Yuanxin Zhiyao Technology Co., Ltd. (a related entity of MetaNovas) continues to drive material innovation through AI, the industry is beginning to glimpse a new possibility: AI is no longer just a scientist's assistant, but a "super agent" capable of completing the entire cycle from discovery to implementation on its own.
Related article
U.S. Stocks Hit Historic Milestone as AI and Aerospace Giants Prepare for Trillion-Dollar Debut
Elon Musk, Sam Altman, and Dario Amodei, three titans of the technology sector, are advancing toward initial public offerings for their respective ventures. With SpaceX, OpenAI, and Anthropic—three industry behemoths nearing trillion-dollar valuation
Swedish AI Startup Lovable Eyes $13.2 Billion Valuation After Major Funding Round
As AI-driven coding tools gain traction, Swedish startup Lovable has secured a major funding round. The company aims to raise $3 billion, potentially boosting its valuation to $13.2 billion—double the $6.6 billion recorded last December. Menlo Ventur
Google Tests Remy AI Agent for Gemini as Focus Shifts to User Control
According to Business Insider, Google is testing Remy, a new AI personal agent for Gemini. This tool aims to execute tasks on behalf of users, streamlining both professional workflows and daily routines.Currently, Remy is undergoing testing in an int
Related Special Topic Recommendations
Comments (0)
0/500

As "AI for Science" gains momentum, molecular research in laboratories is shifting from digitization to intelligentization.
MetaNovas, a tech company at the forefront of commercializing AI-designed new molecular materials, recently announced the successful completion of two funding rounds: Series A+ and Series A++. The round attracted a strong group of investors—Fuhua Capital, Hillhouse Capital, and the Kangaroo Mom Group—all active in the consumer health sector.
Moving Beyond "Generation-Heavy, Implementation-Light": Getting AI Molecules Out of the Lab
For years, AI in molecular research has faced a core challenge: it can generate countless new molecules via algorithms, but efficiently translating them into real-world production remains difficult. MetaNovas' key breakthrough lies in its Agentic AI R&D System:
Full-Chain Integration: Shifting beyond a focus on isolated technical points, it has achieved a critical leap from "AI-designed molecules" to "AI-implemented molecules."
Compliance and Registration: The AI-designed new molecules have successfully completed the full journey from lab research to consumer market application, and have also passed global new material compliance registration.
Capitalizing on the Consumer Health Market: Leading Brands in China and the U.S. Are Already Onboard
Unlike many AI projects still in the theoretical stage, MetaNovas' technology is already deeply embedded in our daily lives.
Implementation Results: Its self-developed new molecules have entered the supply chains of top cosmetics and medical device brands in both China and the United States.
Industrial Empowerment: By leveraging Agentic AI, brand owners can significantly shorten the development cycle for new ingredients and precisely target niche opportunities in the consumer health market.
Investor Confidence: The "Super Agent" Driving New Material Innovation
This funding round will primarily be used to deepen technology R&D and expand its industrial footprint. As Shanghai Yuanxin Zhiyao Technology Co., Ltd. (a related entity of MetaNovas) continues to drive material innovation through AI, the industry is beginning to glimpse a new possibility: AI is no longer just a scientist's assistant, but a "super agent" capable of completing the entire cycle from discovery to implementation on its own.
U.S. Stocks Hit Historic Milestone as AI and Aerospace Giants Prepare for Trillion-Dollar Debut
Elon Musk, Sam Altman, and Dario Amodei, three titans of the technology sector, are advancing toward initial public offerings for their respective ventures. With SpaceX, OpenAI, and Anthropic—three industry behemoths nearing trillion-dollar valuation
Swedish AI Startup Lovable Eyes $13.2 Billion Valuation After Major Funding Round
As AI-driven coding tools gain traction, Swedish startup Lovable has secured a major funding round. The company aims to raise $3 billion, potentially boosting its valuation to $13.2 billion—double the $6.6 billion recorded last December. Menlo Ventur





Home






